Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment

Wayne Clark, Ken P. Madden, Robert Rothlein, Justin A. Zivin

Research output: Contribution to journalArticle

175 Citations (Scopus)

Abstract

Activated leukocytes appear to be directly involved in ischemic central nervous system injury. A surface glycoprotein (CD18) on the leukocyte is required for endothelial adherence and subsequent function and can be blocked with leukocyte adhesion antibody treatment. We used two animal models to determine the efficacy of anti-CD18 antibody treatment in preserving neurologic function after central nervous system ischemia. We gave a dose of 1 mg/kg anti-CD18 to treatment rabbits 30 minutes before inducing irreversible ischemia in the brain with intraarterial microspheres or in the spinal cord using reversible aortic occlusion. Treatment with anti-CD18 produced a significant reduction in neurologic deficits in the reversible spinal cord model, but not in the irreversible microsphere model. This protective effect supports the active role of leukocytes in central nervous system reperfusion ischemic injury and offers potential for future therapy.

Original languageEnglish (US)
Pages (from-to)877-883
Number of pages7
JournalStroke
Volume22
Issue number7
StatePublished - 1991

Fingerprint

Nervous System Trauma
Leukocytes
Central Nervous System
Rabbits
Antibodies
Microspheres
Spinal Cord
Membrane Glycoproteins
Neurologic Manifestations
Reperfusion Injury
Brain Ischemia
Nervous System
Anti-Idiotypic Antibodies
Ischemia
Animal Models

Keywords

  • Cell adhesion
  • Cerebral ischemia
  • Leukocytes
  • Rabbits

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing
  • Neuroscience(all)

Cite this

Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. / Clark, Wayne; Madden, Ken P.; Rothlein, Robert; Zivin, Justin A.

In: Stroke, Vol. 22, No. 7, 1991, p. 877-883.

Research output: Contribution to journalArticle

Clark, Wayne ; Madden, Ken P. ; Rothlein, Robert ; Zivin, Justin A. / Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. In: Stroke. 1991 ; Vol. 22, No. 7. pp. 877-883.
@article{6d4c5375aa6c451c91f4204b102dda66,
title = "Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment",
abstract = "Activated leukocytes appear to be directly involved in ischemic central nervous system injury. A surface glycoprotein (CD18) on the leukocyte is required for endothelial adherence and subsequent function and can be blocked with leukocyte adhesion antibody treatment. We used two animal models to determine the efficacy of anti-CD18 antibody treatment in preserving neurologic function after central nervous system ischemia. We gave a dose of 1 mg/kg anti-CD18 to treatment rabbits 30 minutes before inducing irreversible ischemia in the brain with intraarterial microspheres or in the spinal cord using reversible aortic occlusion. Treatment with anti-CD18 produced a significant reduction in neurologic deficits in the reversible spinal cord model, but not in the irreversible microsphere model. This protective effect supports the active role of leukocytes in central nervous system reperfusion ischemic injury and offers potential for future therapy.",
keywords = "Cell adhesion, Cerebral ischemia, Leukocytes, Rabbits",
author = "Wayne Clark and Madden, {Ken P.} and Robert Rothlein and Zivin, {Justin A.}",
year = "1991",
language = "English (US)",
volume = "22",
pages = "877--883",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment

AU - Clark, Wayne

AU - Madden, Ken P.

AU - Rothlein, Robert

AU - Zivin, Justin A.

PY - 1991

Y1 - 1991

N2 - Activated leukocytes appear to be directly involved in ischemic central nervous system injury. A surface glycoprotein (CD18) on the leukocyte is required for endothelial adherence and subsequent function and can be blocked with leukocyte adhesion antibody treatment. We used two animal models to determine the efficacy of anti-CD18 antibody treatment in preserving neurologic function after central nervous system ischemia. We gave a dose of 1 mg/kg anti-CD18 to treatment rabbits 30 minutes before inducing irreversible ischemia in the brain with intraarterial microspheres or in the spinal cord using reversible aortic occlusion. Treatment with anti-CD18 produced a significant reduction in neurologic deficits in the reversible spinal cord model, but not in the irreversible microsphere model. This protective effect supports the active role of leukocytes in central nervous system reperfusion ischemic injury and offers potential for future therapy.

AB - Activated leukocytes appear to be directly involved in ischemic central nervous system injury. A surface glycoprotein (CD18) on the leukocyte is required for endothelial adherence and subsequent function and can be blocked with leukocyte adhesion antibody treatment. We used two animal models to determine the efficacy of anti-CD18 antibody treatment in preserving neurologic function after central nervous system ischemia. We gave a dose of 1 mg/kg anti-CD18 to treatment rabbits 30 minutes before inducing irreversible ischemia in the brain with intraarterial microspheres or in the spinal cord using reversible aortic occlusion. Treatment with anti-CD18 produced a significant reduction in neurologic deficits in the reversible spinal cord model, but not in the irreversible microsphere model. This protective effect supports the active role of leukocytes in central nervous system reperfusion ischemic injury and offers potential for future therapy.

KW - Cell adhesion

KW - Cerebral ischemia

KW - Leukocytes

KW - Rabbits

UR - http://www.scopus.com/inward/record.url?scp=0025768180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025768180&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 877

EP - 883

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 7

ER -